(Date:11/20/2008)...SSELS, BELGIUM A team of researchers at Duke Univ... de Louvain (UCL) has found that lactic acid is an...er experiments, they discovered a new way to destr... preventing them from delivering lactic acid. ,...xygen, or hypoxic, cells cause resistance to radia...
(Date:11/20/2008)...wswire/ -- The UNICEF supported clean-water,campa... water technology,manufacturer, The Watergeeks La...he campaign in 2009 -- the third year of this awar...provide clean water to children around the world. ...sed manufacturer will donate a,percentage of the ...
(Date:11/20/2008)...tes over $35,000 from Velocity hearing instrument ...ire-FirstCall/ -- Sonic Innovations, Inc. (Nasdaq:... the Armed Forces Foundation (AFF) during a check ...nt and COO Paul Wennerholm and AFF President and E... D.C. The donation is the result of a program con...
(Date:11/20/2008)...st infection that can cause meningitis, pneumonia ... 20 (HealthDay News) -- U.S. health officials said...em to monitor Hib infections, one of the most impo...n. , Though the agency has yet to see an increa...ted by a disruption in the supply of vaccine that ...
Breaking Medicine News(10 mins):Health News:Lactic acid found to fuel tumors 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 2Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 3Health News:CDC Monitors Shortage of Hib Vaccine 2Health News:CDC Monitors Shortage of Hib Vaccine 3(Date:11/20/2008)...re-FirstCall/ -- PAREXEL International Corporation...ical services provider, today announced that it ha...tory consulting and clinical research capabilities...w has locations throughout five important biopharm...lude Argentina, Brazil, Chile, and Mexico. This ex...
(Date:11/19/2008)... achieve statistical significance , , ISELI...s Corporation (Nasdaq: PARS ) today announced re...cal NanoEmulsion (NE) drug delivery technology for..., The multi-center, randomized, double-blinded, ...efficacy of the Company,s 3% Diclofenac Diethanola...
(Date:11/19/2008)...ent from Roche- , , MONTVALE, N.J., Nov. 19...Corp. (Nasdaq: MEMY ) today announced that it ha...al of R3487/MEM 3454, its lead alpha-7 nicotinic r...d with schizophrenia (CIAS). The Company has rand...ng a $5.0 million payment from its partner Roche. ...
(Date:11/18/2008)...PRNewswire-USNewswire/ -- Forty-two leading U. S. ...national forum to consider cutting-edge innovation...onal economy from outbreaks of dangerous zoonotic ..., Among those innovations: , , , , ...able that detects highly contagious and dangerous ...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Assured Pharmacy Consolidates Portland Oregon Pharmacy 3306 1Assured Pharmacy Consolidates Portland Oregon Pharmacy 3306 2Assured Pharmacy Consolidates Portland Oregon Pharmacy 3306 3AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 1AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 2AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 3AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 4AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 5AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 6AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 7AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 8AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 9AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 10AtriCure Reports Fourth Quarter and Full Year 2007 Record Financial Results 11906 11Eklin Medical Reports Record Revenues for 2007 3303 1Eklin Medical Reports Record Revenues for 2007 3303 2Eklin Medical Reports Record Revenues for 2007 3303 3Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th 11903 1Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th 11903 2...ta on Eloxatin(R), Taxotere(R) and on three invest...ll be presented at the 43rd,annual ASCO meeting, B...ll/ --,Sanofi-aventis announced today that a total...tment have been accepted for the,43rd Annual Meeti...SCO) in Chicago, Illinois (June 1-5, 2007). The re...
...History Highlighted in AACR Cancer Journal , AUSTI...Therapeutics, Inc. (NASDAQ:INGN) announced today t...nical benefit of its lead product,Advexin in a pat...,Li-Fraumeni Syndrome (LFS), a genetic disorder ch...r suppressor gene. This is the,first reported trea...
Other Medicine Technology:Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: